Spencer Pharmaceutical (SPPH)

[scion]

An ex-associate of the husband of Marois interested the Americans

April 2, 2014 6:44 |
Jean -François Cloutier / Investigation Bureau
Updated April 2, 2014 at 6:45 amA

A former partner of the husband of Pauline Marois, Claude Blanchet, and an advisor to the Canadian Senate, are two witnesses that U.S. investigators with the Securities and Exchange Commission want to question in a nebula stock manipulation case involving Quebec .

According to court documents obtained by our Bureau of Investigation , the Securities and Exchange Commission ( SEC) has approached a court in Boston, there is a month for permission to interview the man in Montreal, businessman Jean -Guy Lambert, and an advisor to the Senate Foreign Affairs , Rami Ailabouni.

Eight other witnesses are also affected by the request of the SEC, the U.S. equivalent of the AMF market ( AMF ) in Quebec.

The case concerns Spencer Pharmaceutical, a U.S. pharmaceutical company officially , but in fact controlled from Montreal , according to the SEC. It filed charges in December 2012 against Jean- Francois Amyot , 40, Maximilien Arella , 59, and Ian Morrice , 52, in this case.

According to what is alleged in court documents, Amyot would have led " a ploy to falsely promote the activities of the company, Spencer Pharmaceutical, and a false bid for the company," with the help of Arella and Morrice .The aim was "to profit from the sale of shares of Spencer at an inflated price ."Technology supposedly developed by Spencer was bogus.

Amyot reportedly sold for U.S. $ 5.8 million shares via shell companies, according to the SEC.

Party in the Bahamas

Jean- Francois Amyot controls IAB Media and Hilbroy Advisory.

The two companies involved in stock promotions, are subject to a restraint order of the MFA since 2011, confirmed the spokesperson Sylvain Théberge. They are also affected by the continuation of the SEC case. According to our information , he left Montreal to live in the Bahamas, a tax haven, shortly before the filing of charges against him.

Maximilien Arella is a retired teacher. He worked at the National Institute of Scientific Research ( INRS) .

Ian Morrice is vice president and director of Spencer. It was not possible to speak or to Jean -François Amyot nor Ian Morrice .

Maximilien Arella , reached by telephone , would not comment.

In its defense, filed on March 19, he categorically rejects the accusations against him." I realize that my experience and my scientific projects have been used against my will in a potential ploy " pump and dump " ," he said. He said he trusted Amyot because of the people around him."People around Mr. Amyot ( ... ) and all of its officers were top political figures placed very close to the Prime Minister and some ministers and senators. "The ex- partner said he was surprised.

When contacted, Jean -Guy Lambert said he was very surprised by the fact that the SEC wants to talk to him, "You tell me."

Allegations against Amyot, listed in the documents, state that he would have received a share of the proceeds of a fund used by Amyot, are totally false, he said. "I lost a lot of money with that," he said.He said he had ceded control to Amyot a company called Emergensys , which was then renamed Spencer Pharmaceutical.

Jean -Guy Lambert is CEO of Dacha Capital, a company funding various projects of venture capital in Québec.

Dacha has invested in Distinction Group, a giant in housekeeping. In an interview, he defined himself as a former " close associate " of Claude Blanchet. It was as a shareholder and director in Dacha and Distinction. " He contacted me when he left the SGF and I invited him on my board of directors," he said.

Rami Aibalouni could not be reached. A man called to speak for her and posing as his friend , said he could not talk about yet ." What is written in the documents, it is just 25 % of the story. There are many ramifications, "said he said.


- A loose translation
http://argent.canoe.ca/nouvelles/un-ex-associe-du-mari-de-marois-interesse-les-americains-2042014